![Michael K. Schultz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael K. Schultz
Technik-/Wissenschafts-/F&E-Leiter bei PERSPECTIVE THERAPEUTICS, INC.
Aktive Positionen von Michael K. Schultz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PERSPECTIVE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Viewpoint Molecular Targeting, Inc.
![]() Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Gründer | 01.01.2008 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.08.2013 | - | |
Direktor/Vorstandsmitglied | 01.01.2008 | - |
Karriereverlauf von Michael K. Schultz
Ehemalige bekannte Positionen von Michael K. Schultz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
National Institute of Health Policy | Corporate Officer/Principal | - | - |
University of Iowa | Corporate Officer/Principal | - | - |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Viewpoint Molecular Targeting, Inc.
![]() Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Commercial Services |
National Institute of Health Policy |
- Börse
- Insiders
- Michael K. Schultz
- Erfahrung